Zhang Tao, Enemchukwu Nduka O, Jones Alex, Wang Shixian, Dennis Emily, Watt Carl B, Pugh Edward N, Fu Yingbin
Department of Ophthalmology and Visual Sciences.
Physiology and Membrane Biology, University of California, Davis, 3301 Tupper Hall, 1 Shields Avenue, Davis, CA 95616, USA.
Hum Mol Genet. 2015 Mar 15;24(6):1755-63. doi: 10.1093/hmg/ddu588. Epub 2014 Nov 20.
Mutations in RPE65 or lecithin-retinol acyltransferase (LRAT) disrupt 11-cis-retinal synthesis and cause Leber congenital amaurosis (LCA), a severe hereditary blindness occurring in early childhood. The pathology is attributed to a combination of 11-cis-retinal deficiency and photoreceptor degeneration. The mistrafficking of cone membrane-associated proteins including cone opsins (M- and S-opsins), cone transducin (Gαt2), G-protein-coupled receptor kinase 1 (GRK1) and guanylate cyclase 1 (GC1) has been suggested to play a role in cone degeneration. However, their precise role in cone degeneration is unclear. Here we investigated the role of S-opsin (Opn1sw) in cone degeneration in Lrat(-) (/-), a murine model for LCA, by genetic ablation of S-opsin. We show that deletion of just one allele of S-opsin from Lrat(-) (/-) mice is sufficient to prevent the rapid cone degeneration for at least 1 month. Deletion of both alleles of S-opsin prevents cone degeneration for an extended period (at least 12 months). This genetic prevention is accompanied by a reduction of endoplasmic reticulum (ER) stress in Lrat(-) (/-) photoreceptors. Despite cone survival in Opn1sw(-/-)Lrat(-) (/-) mice, cone membrane-associated proteins (e.g. Gαt2, GRK1 and GC1) continue to have trafficking problems. Our results suggest that cone opsins are the 'culprit' linking 11-cis-retinal deficiency to cone degeneration in LCA. This result has important implications for the current gene therapy strategy that emphasizes the need for a combinatorial therapy to both improve vision and slow photoreceptor degeneration.
视网膜色素上皮特异性 65 蛋白(RPE65)或卵磷脂 - 视黄醇酰基转移酶(LRAT)的突变会破坏 11 - 顺式视黄醛的合成,导致莱伯先天性黑蒙(LCA),这是一种在幼儿期出现的严重遗传性失明。其病理归因于 11 - 顺式视黄醛缺乏和光感受器退化的综合作用。有人提出,包括视锥视蛋白(M - 和 S - 视蛋白)、视锥转导素(Gαt2)、G 蛋白偶联受体激酶 1(GRK1)和鸟苷酸环化酶 1(GC1)在内的视锥膜相关蛋白的错误运输在视锥退化中起作用。然而,它们在视锥退化中的确切作用尚不清楚。在这里,我们通过基因敲除 S - 视蛋白,研究了 S - 视蛋白(Opn1sw)在 Lrat(- / -)(一种 LCA 的小鼠模型)视锥退化中的作用。我们发现,从 Lrat(- / -)小鼠中仅删除一个 S - 视蛋白等位基因就足以在至少 1 个月内防止视锥的快速退化。删除 S - 视蛋白的两个等位基因可在较长时间内(至少 12 个月)防止视锥退化。这种基因预防伴随着 Lrat(- / -)光感受器内质网(ER)应激的减轻。尽管 Opn1sw(- / -)Lrat(- / -)小鼠中的视锥得以存活,但视锥膜相关蛋白(如 Gαt2、GRK1 和 GC1)仍存在运输问题。我们的结果表明,视锥视蛋白是将 LCA 中 11 - 顺式视黄醛缺乏与视锥退化联系起来的“罪魁祸首”。这一结果对当前的基因治疗策略具有重要意义,该策略强调需要联合治疗以改善视力并减缓光感受器退化。